Page 6 - Imedtech Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: May 24, 2021 SINGAPORE, May 23, 2021 /PRNewswire/ -- Genesis MedTech Group ("Genesis"), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital and others. The majority of shareholders from Series A followed up with additional investments. Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors. The funds will be used to drive the rese...

Credit: Epic MegaGrant Interventions on fetuses can treat potentially very serious conditions for unborn babies and are among the most challenging to perform due to difficulty of access, reduced vision and manoeuvrability, a lack of information about what to expect once inside the patient, and the patient's extreme fragility. In recent years, to achieve a realistic simulation of the patient, major breakthroughs have been achieved in medical imaging techniques, AI and mixed reality. These advances are of paramount importance to surgeons as they enable them to plan surgery well in advance and t...

Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China - Partnership to be in tandem with formation of Genesis Medtech's Neurovascular Franchise, pending an ongoing full acquisition of Hua Medtech - The collaboration will position Genesis MedTech ("Genesis") as the largest local company in China's neurovascular space News provided by Share this article Share this article SINGAPORE, Jan. 19, 2021 /PRNewswire/ -- Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialised neurovascular franchise, which has e...